Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$525.28 USD

525.28
842,078

-0.66 (-0.13%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $525.55 +0.27 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

McKesson (MCK) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

McKesson's (MCK) fiscal fourth-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions and Medical-Surgical Solutions segments.

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sriparna Ghosal headshot

3 MedTech Stocks Likely to Have Braved Coronavirus Blow in Q1

by Sriparna Ghosal

Despite the widespread coronavirus crisis, there are a few MedTech companies which are expected to have gained in the first quarter.

ResMed (RMD) Grows on Stellar Mask Sales, SaaS Capabilities

by Zacks Equity Research

Within SaaS, ResMed (RMD) shows strong momentum in the Brightree service portfolio.

Here's Why You Should Hold on to Luminex (LMNX) Stock Now

by Zacks Equity Research

Luminex (LMNX) continues to benefit from robust product portfolio, solid molecular diagnostics and ARIES platforms.

BD (BDX) Receives EUA for New Coronavirus Detection Test

by Zacks Equity Research

Becton, Dickinson (BDX) receives EUA from the FDA for another molecular diagnostic test for COVID-19, which can return results in two to three hours.

Here's Why You Should Invest in Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) continues to gain traction from its robustly performing CVI and CSI businesses.

Masimo SafetyNet to Help Clinicians Fight Coronavirus Better

by Zacks Equity Research

Masimo (MASI) announces the full market release of Masimo SafetyNet, which is a remote patient management solution that will help in the fight against the COVID-19 pandemic.

Should Value Investors Buy McKesson (MCK) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why You Should Hold on to Stryker (SYK) Stock Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.

Here's Why You Should Hold on to Avanos Medical Stock Now

by Zacks Equity Research

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

MCK vs. COO: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. COO: Which Stock Is the Better Value Option?

Coronavirus Hits S&P 500: 4 MedTech Stocks That Fared Better

by Zacks Equity Research

Here are a few MedTech companies which have outperformed the S&P 500 index in the past two months.

Here's Why You Should Add Integer Holdings to Your Portfolio

by Zacks Equity Research

Integer Holdings (ITGR) continues to gain traction from solid presence in the broader MedTech space and portfolio management.

Should iShares Morningstar Mid-Cap Value ETF (JKI) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for JKI

Can Retail Pharmacy USA Aid Walgreen Boots' (WBA) Q2 Earnings?

by Zacks Equity Research

Solid prescription volume growth and brand inflation anticipated to have aided Walgreen Boots' (WBA) Retail Pharmacy USA performance in Q2.

Here's Why You Should Invest in McKesson (MCK) Stock Now

by Zacks Equity Research

McKesson (MCK) continues to gain traction from its multi-year strategic growth initiative and distribution solutions segment.

Is McKesson (MCK) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MCK vs. COO: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

MCK vs. COO: Which Stock Is the Better Value Option?

Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (MCK) Outperforming Other Medical Stocks This Year?

Implied Volatility Surging for McKesson (MCK) Stock Options

by Zacks Equity Research

Investors need to pay close attention to McKesson (MCK) stock based on the movements in the options market lately.

Is McKesson (MCK) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Why Is McKesson (MCK) Up 0.1% Since Last Earnings Report?

by Zacks Equity Research

McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MCK or WST: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MCK vs. WST: Which Stock Is the Better Value Option?

Why McKesson (MCK) Could Be a Top Value Stock Pick

by Zacks Equity Research

McKesson (MCK) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.